Sukhatme Mayukh bought ROIV
December 31, 2025 · Form 4 insider transaction
Sukhatme Mayukh bought 2,449,877 shares of Roivant Sciences Ltd. at $12.68 per share, a transaction worth $31.06M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,449,877
Price
$12.68
Total value
$31.06M
InsiderSukhatme Mayukh
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateDecember 31, 2025
Filing dateDecember 31, 2025
Shares owned after21,286,424
OwnershipDirect
10b5-1 planNo
AmendedNo